TNF receptor deficiency reveals a translational control mechanism for adriamycin-induced Fas expression in cardiac

Yu-Chin Lien1, Chotiros Daosukho, Daret K St Clair

  • 1Graduate Center for Toxicology, University of Kentucky, Lexington, KY 40536, USA.

Cytokine
|April 18, 2006
PubMed

Insights

Adriamycin (ADR) causes heart cell death. Tumor necrosis factor (TNF) receptors protect against ADR toxicity by regulating Fas expression at the protein level, not the mRNA level.

Area of Science:

  • Cardiovascular research
  • Molecular biology
  • Cancer therapeutics

Background:

  • Adriamycin (ADR) induces cardiomyocyte apoptosis through the Fas/Fas ligand pathway.
  • Tumor necrosis factor-alpha (TNF-alpha) receptors may offer cardioprotection against ADR toxicity by suppressing Fas-mediated cell death.
  • The precise role of TNF-alpha receptors in modulating ADR-induced Fas expression remains unclear.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which ADR induces Fas expression.
  • To investigate the role of TNF-alpha receptors in this process, particularly at transcriptional and translational levels.

Main Methods:

  • Examining ADR-induced Fas expression in the presence and absence of TNF receptors.
  • Analyzing p53 and AP-1 interactions and Fas mRNA levels.
  • Quantifying Fas protein levels in cardiac tissues of wild-type and TNF receptor-deficient mice.

Main Results:

  • ADR-mediated p53 and AP-1 interaction increased Fas mRNA levels independently of TNF receptors.
  • Fas protein levels were elevated in cardiac tissues of TNF receptor-deficient mice but not in wild-type mice.
  • TNF receptors suppress ADR-induced Fas expression at a post-transcriptional (translational) level.

Conclusions:

  • TNF receptors do not affect ADR-induced Fas mRNA transcription.
  • TNF receptors play a crucial role in suppressing ADR-induced Fas protein accumulation, likely via translational regulation.
  • Understanding this mechanism could lead to novel cardioprotective strategies against chemotherapy-induced cardiotoxicity.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: